Clinical Trials
24
Active:1
Completed:20
Trial Phases
3 Phases
Phase 2:1
Phase 3:2
Phase 4:14
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (17 trials with phase data)• Click on a phase to view related trials
Phase 4
14 (82.4%)Phase 3
2 (11.8%)Phase 2
1 (5.9%)A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple Myeloma
- First Posted Date
- 2014-10-20
- Last Posted Date
- 2016-07-11
- Lead Sponsor
- Johnson & Johnson Taiwan Ltd
- Target Recruit Count
- 18
- Registration Number
- NCT02268890
A Post-Approval Pharmacokinetic Study of Bortezomib in Participants With Multiple Myeloma
- First Posted Date
- 2013-02-28
- Last Posted Date
- 2013-05-16
- Lead Sponsor
- Johnson & Johnson Taiwan Ltd
- Target Recruit Count
- 14
- Registration Number
- NCT01801436
A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia
Phase 4
Terminated
- Conditions
- Schizophrenia
- Interventions
- First Posted Date
- 2012-08-21
- Last Posted Date
- 2016-04-13
- Lead Sponsor
- Johnson & Johnson Taiwan Ltd
- Target Recruit Count
- 17
- Registration Number
- NCT01670071
First Add-on vs. Mono-therapy Study of Topiramate in Neuro-Surgical Patients
Phase 4
Completed
- Conditions
- Epilepsy
- Interventions
- First Posted Date
- 2012-06-26
- Last Posted Date
- 2013-10-29
- Lead Sponsor
- Johnson & Johnson Taiwan Ltd
- Target Recruit Count
- 55
- Registration Number
- NCT01627860
Symptomatic Remission and Social Function in Participants Treated With Paliperidone Extended Release (ER)
- First Posted Date
- 2012-04-13
- Last Posted Date
- 2014-01-17
- Lead Sponsor
- Johnson & Johnson Taiwan Ltd
- Target Recruit Count
- 480
- Registration Number
- NCT01577186
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
News
No news found